In Vitro Toxicology Testing Market - Analysis, Size, Share, Growth, Market Demand and Forecasts to 2022 Along with Top Key Players

In Vitro Toxicology Testing Market is expected to reach $8.74 Billion by 2022

(EMAILWIRE.COM, October 06, 2018 ) According to the new market research report "In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (ADME, Skin, Genotoxicity, Organ Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays, Ex-Vivo), Industry (Pharmaceutical, Cosmetics) - Forecast to 2022", published by MarketsandMarkets™,The in vitro toxicology testing market is expected to reach USD 8.74 Billion by 2022 from an estimated USD 6.34 Billion in 2017, at a CAGR of 6.6%.
Don’t miss out on business opportunities in In Vitro Toxicology Testing Market. Speak to our analyst and gain crucial industry insights that will help your business grow:
https://www.marketsandmarkets.com/speaktoanalyst.asp?id=209577065
Cell culture technology to hold the largest market share in 2017
Based on technology, the in vitro toxicology testing market is segmented into cell culture technologies, high-throughput technologies, cellular imaging technologies, and toxicogenomics. The toxicogenomics segment is expected to account for the highest CAGR in the global in the vitro toxicology testing market. Toxicogenomics is preferred to elucidate the changes in gene expression in response to toxic exposure and facilitates to identify toxicity pathways.
Based on toxicity endpoints and tests of in vitro toxicology testing, the market is subsegmented into ADME, genotoxicity, skin irritation and sensitization, cytotoxicity, ocular toxicity, organ toxicity, phototoxicity, dermal toxicity, and other toxicities (eco toxicity, endocrine disruption, and reproductive & developmental toxicity). In 2017, the ADME segment is expected to account for the largest share of the global in vitro toxicology testing market owing to its highly reproducible & accurate data and the increasing demand to curb drug toxicity at the drug development phase.
Browse and in-depth TOC on "In Vitro Toxicology Testing Market"
139 - Tables
32 - Figures
253 - Pages
View more detailed TOC @
https://www.marketsandmarkets.com/Market-Reports/in-vitro-toxicology-testing-market-209577065.html
US is estimated to account for the largest share among other regions in the in vitro toxicology testing market, followed by Germany and UK. In the Asia Pacific region, China is expected to grow at the highest CAGR during the forecast period.
Request For Free Brochure @
https://www.marketsandmarkets.com/pdfdownload.asp?id=209577065
The global in vitro toxicology testing market is projected to reach USD 8.74 Billion by 2022 from USD 6.34 Billion in 2017, at a CAGR of 6.6% during the forecast period. This market is fragmented in nature with a large number of regional and national players. In 2016, Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), and Eurofins Scientific SE (Luxembourg) were the top three players in the in vitro toxicology testing market and accounted for approximately 40% share of the overall market.

Thermo Fisher Scientific dominated the global vitro toxicology testing market in 2016. The company offers approximately 100 toxicology assays kits and supplementary products for this market, Invitrogen and Gibco being its major brands. The company strategically acquired Affymetrix, Inc. (US) in 2016 to strengthen its offerings in clinical and applied markets. Additionally, the company is backed by its broad global reach, especially in the emerging markets.

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com